Hyperuricaemia and essential hypertension: a case control study in Southern Rajasthan

Chanchal Shrivastav, Suman Sharma, M. L. Suhalka, Manjinder Kaur


Background: Hypertension is one of the current emerging community health problems, which is very common affecting one in four individuals. Hyperuricemia is predictive for the development of both hypertension and coronary artery disease. Since there are various etiological factors associated with hypertension so it is very difficult to predict which one is the most common cause of hypertension. Little or no information is present in the population of Rajasthan, on the association between serum uric acid and essential hypertension. Hence this study is carried out to investigate the existence of an association between serum uric acid and essential hypertension.

Methods: In this hospital based case control study, a total of 75 newly diagnosed essential hypertensive cases, 75 prehypertensive cases and 50 normotensive healthy controls, aged 20-50 years of both sexes were enrolled after excluding gout, diabetes mellitus, cardiovascular diseases, renal diseases, metabolic syndrome, secondary hypertension or history of having relevant drugs by taking detailed history and physical examination. Serum uric acid was measured in all study cases as well as control subjects.

Results: The results of our study revealed that the mean serum uric acid level and the frequency of subjects with increased serum uric acid level were significantly higher in newly diagnosed cases of essential hypertension as compared to prehypertensive and normotensive controls (p< 0.001). Serum uric acid correlated positively with systolic blood pressure (SBP) (r= + 0.23, p<0.05) and diastolic blood pressure (DBP) (r= + 0.09, p>0.05). These results indicate a definite association between hyperuricaemia and essential hypertension.

Conclusions: In the present study, Elevated level of SUA is significantly linked with PreHT and EHT after controlling various confounding factors. The present study showed that the number of hyperuricaemic individuals and mean SUA level were significantly higher in newly diagnosed cases of hypertension as compared to prehypertensive and normotensive control.



Serum uric acid, Borderline hypertension/Prehypertension, Essential hypertension

Full Text:



Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB. Impact of high – normal blood pressure on the risk of cardiovascular diseases. N Engl J Med. 2001;345(18):1291-97.

Das SK, Sanyal K, Basu A. Study of urban community survey in India: growing trend of high prevalence of hypertension in a developing country. Int J Med Sci. 2005;2(2):70-8.

Roddy E. Hyperuricaemia, gout and lifestyle factors. J Rheumatol. 2008;35:1689-91.

Choi HK. A prescription for lifestyle change in patients with hyperuricaemia and gout. Curr Opin Rheumatol. 2010;22:165-72.

Sundström J, Sullivan L, D’Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of SUA to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005;45(1):28-33.

Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension. 2003;42:247-52.

Mazzali M, Hughes J, Kim YG, Jefferson A, Kang DH, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001;38:1101-6.

Feig DI, Nakagawa T, Karumanchi SA, Oliver WJ, Kang DH, Finch J. Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int. 2004,66:281-7.

Gupta R. trends in hypertension epidemiology in india. J Hum Hypertens. 2004;18:73-8.

Chobanion AV, Bakris GL, Black GL, Black HR. The Seventh Report of the Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure: The JNC7 Report. JAMA. 2003;289(19):2560-72.

Trinder P. Quantitative determination of Uric Acid in human serum. J Clin Pathol. 1949;22:246-50.

Bowers LD, Wong ET. Kinetic serum creatinine assays II. A critical evaluation and review. Clin. Chem. 1980;26:555-61.

Bergmayer HV. Methods of enzymatic analysis. A.P, N.Y. 1974;1196.

Hochberg MC, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology, 3rd E.D.Mosby, New York, 2003.

Selby JV, Friedman GD, Quesenberry CP. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol. 1990;131:1017-27.

Cannon PJ, Stanson WB, Demartini FE, Sommmers SC, Laragh JH. Hyperuricaemia in primary and renal hypertension. N Engl J Med. 1966;275:457-64.

Kahn HA, Medalie JH, Neufeld HN, Riss E, Goldbourt U. The incidence of hypertension and associated factors: The Israel ischemic heart disease study. Am Heart J. 1972;84:171-82.

Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentration predict subsequent weight gain and blood pressure elevation. Hypertension. 2003;42:474-80.

Puig JG, Ruilope LM. Uric acid as a cardiovascular risk factor in arterial hypertension. Journal of Hypertension. 1999;17:869-72.

Shah MI, Suthar RK, Soomro MA. Esential hypertension: Evaluation of serum uric acid at tertiary care hospital, Hyderabad/Jamshoro. The professional medical J. 2015;22(7):854-8.

Vittal BG, Bhaskra K, Naveenkumar GH. Uric acid and hypertension: Does uric acid licks the joints and bites the heart. IJMRHS. 2013;3(1):104-9.

Turankar SA, Sonune K, Turankar AV. Study of serum uric acid in newly diagnosed essential hypertensive patients. World Research J of Critical Care. 2013;1(1):15-7.

Vyas A, Patel NR, Vyas K. A study of correlation between essential hypertension and hyperuricaemia. 2013;7(2):76-9.

Kashem MA, Hossain MZ, Ayaz KMF, Alam MB, Khan MH, Alam ABMM, et al. Relation of serum uric acid level and essential hypertension among patients without metabolic syndrome. J Dhaka Med Coll. 2011;20(1):5-8.

Acharya V, Mishra PK. Hyperuricemia and oxidative stress in borderline hypertension. Research paper, Biomedicine. 2007;21(1):19-22.

Assob JCN, Ngowe MN, Nsagha DS, Njunda AL, Waidim Y, Lemuh DN, et al. The relationship between uric acid and hypertension in Fako division, SW Region Cameroon. J Nutr Food Sci. 2014;4(1):257.

Hamdani IHAL. Estimation of Serum Uric Acid, Urea and Creatinine in Essential Hypertensive Patients. Tikrit Medical Journal. 2010;16(1):152-8.

Vucak J, Katic M, Bielen L, Vrdoljak D, Lalic DL, Kranjcevic K et al. Association between hyperuricaemia, prediabetes, and prehypertension in the Croatian adults population – a cross sectional study. BMC Cardiovascular Disorders. 2010;12:117.

Kuroczycka-Saniutycz E, Wasilewska A, Sulik A, Milewski R. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension. Pediatr Nephrol. 2013;28:1113-19.

Zhou X, Matavelli L, Frohlich ED. Uric acid: its relationship to renal hemodynamics and the renal renin-angiotensin system. Curr Hypertens Rep. 2006;8:120-4.

Babinska K, Kovacs L, Janko V, Dallos T, Feber J. Association between obesity and the severity of ambulatory hypertension in children and adolescents. J Am Soc Hypertens. 2012;6:356-63.

Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005;69:928-33.

Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008;26:269-75.

Higashi Y, Kihara Y, Noma K. Endothelial dysfunction and hypertension in aging. Hypertens Res. 2012;35:1039-47.

Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16:3553-62.

Feig DI. The Role of Uric Acid in th Pathogenesis of Hypertension in the Young. J Clin Hypertens. 2012;14:346-52.

Gruskin AB. The adolescent with essential hypertension. Am J Kidney Dis. 1985;6:86-90.